TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
The association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been...
Saved in:
| Main Authors: | Gang Yu, Wanjing Chen, Xianghua Li, Liang Yu, Yanyan Xu, Qiang Ruan, Yawei He, Yong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2022/5374262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of apatinib in combination treatment versus apatinib as second-line treatment for advanced gastric cancer
by: Zhang Han, et al.
Published: (2025-04-01) -
Recent Advances in CBP/EP300 Degraders
by: Leonardo Palaferri, et al.
Published: (2025-03-01) -
Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer
by: Zhiwei Li, et al.
Published: (2025-07-01) -
Efficacy and safety of apatinib in the second-line treatment of advanced gastric cancer
by: GUO Mengya, CHEN Yue, PENG Weiwei, SHA Huanhuan, FANG Ying, ZHOU Guoren
Published: (2025-01-01) -
LncRNA EP300-AS1 interacts with PTBP1 to destabilize PRMT5 mRNA and suppresses NSCLC growth and metastasis
by: Jingyi Chen, et al.
Published: (2025-08-01)